Biogen (BIIB)

Biogen (BIIB) Financial Statements


Biogen Financial Overview

Biogen's market cap is currently ―. The company's EPS TTM is $10.057; its P/E ratio is 23.79; Biogen is scheduled to report earnings on February 1, 2024, and the estimated EPS forecast is $3.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 2.53B$ 1.85B$ 1.76B$ 2.54B$ 2.51B
Gross Profit$ 1.87B$ 1.97B$ 1.69B$ 1.97B$ 2.04B
EBIT$ -77.40M$ 757.20M$ 375.80M$ 658.60M$ 1.43B
EBITDA$ 277.30M$ 874.60M$ 488.10M$ 833.60M$ 1.55B
Net Income Common Stockholders$ 154.70M$ 591.60M$ 387.90M$ 550.40M$ 1.13B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 6.08B$ 5.04B$ 4.89B$ 4.91B
Total Assets$ 28.19B$ 25.16B$ 24.60B$ 24.55B$ 24.85B
Total Debt$ 7.72B$ 6.59B$ 6.61B$ 6.61B$ 6.63B
Net Debt$ 7.72B$ 510.70M$ 1.57B$ 1.72B$ 1.72B
Total Liabilities$ 13.71B$ 10.70B$ 10.81B$ 11.17B$ 12.09B
Stockholders Equity$ 14.48B$ 14.47B$ 13.80B$ 13.40B$ 12.78B
Cash Flow-
Free Cash Flow$ 714.50M$ 400.00M$ 383.70M$ -262.40M$ 601.90M
Operating Cash Flow$ 1.05B$ 487.00M$ 455.30M$ -175.00M$ 661.00M
Investing Cash Flow$ -2.70B$ -753.50M$ -953.00M$ -141.10M$ 1.67B
Financing Cash Flow$ 805.20M$ -9.80M$ -43.40M$ -7.40M$ -1.25B
Currency in USD

Biogen Earnings and Revenue History

Biogen Debt to Assets

Biogen Cash Flow

Biogen Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis